LongCovid
The current lack of Long COVID biomarkers and pathophysiological mechanisms limits effective diagnosis, treatment and disease surveillance. This study, recently published by Molecular Medicine, performed targeted proteomics and machine learning analyses to identify novel blood biomarkers of Long-COVID.
“Optimal protein models, as well as individual proteins, hold the potential for accurate diagnosis of Long COVID and targeted therapeutics”
“Widespread cases of long covid have shone a spotlight on the role viral infections play in previously neglected conditions like chronic fatigue syndrome and fibromyalgia.” This New Scientist…
Why do some people infected with COVID-19 develop postacute sequelae of COVID-19 (PASC) while others do not? This is the question that Herman et al. try to answer with…
Stéphanie Longet caught the virus she had worked on for 2 years & now has trouble walking, bringing a personal dimension to her work & a will to find…
The World Health Organization has joined the US CDC and HHS in providing new guidance on the ongoing public health threat posed by Long Covid. World Health Organization…